97 related articles for article (PubMed ID: 7490451)
1. A method for preparing chelate-cytokine conjugates with retention of protein structure, biological activity, and pharmacokinetic properties.
Litzinger DC; Ransone CM; Ralph LD; Laderach W; Whitcomb KL; Woodward MA; Niven RW; Treuheit MJ
J Immunol Methods; 1995 Nov; 187(1):151-61. PubMed ID: 7490451
[TBL] [Abstract][Full Text] [Related]
2. Site-specific conjugation of diethylenetriaminepentaacetic acid to recombinant human granulocyte-colony-stimulating factor: preservation of protein structure and function.
Ralph LD; Ransone CM; Treuheit M; Lauren S; Katta V; Litzinger DC
Biochemistry; 1995 Apr; 34(14):4889-97. PubMed ID: 7536471
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains.
Wen X; Wu QP; Lu Y; Fan Z; Charnsangavej C; Wallace S; Chow D; Li C
Bioconjug Chem; 2001; 12(4):545-53. PubMed ID: 11459459
[TBL] [Abstract][Full Text] [Related]
5. Easy and efficient (111)indium labeling of long-term stored DTPA conjugated protein.
Nalla A; Buch I; Hesse B
Curr Radiopharm; 2011 Jan; 4(1):1-4. PubMed ID: 22191609
[TBL] [Abstract][Full Text] [Related]
6. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates.
Paxton RJ; Jakowatz JG; Beatty JD; Beatty BG; Vlahos WG; Williams LE; Clark BR; Shively JE
Cancer Res; 1985 Nov; 45(11 Pt 2):5694-9. PubMed ID: 4053042
[TBL] [Abstract][Full Text] [Related]
7. Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.
Bass LA; Lanahan MV; Duncan JR; Erion JL; Srinivasan A; Schmidt MA; Anderson CJ
Bioconjug Chem; 1998; 9(2):192-200. PubMed ID: 9548534
[TBL] [Abstract][Full Text] [Related]
8. The stability in liver homogenates of indium-111 and yttrium-90 attached to antibody via two popular chelators.
Mardirossian G; Wu C; Hnatowich DJ
Nucl Med Biol; 1993 Jan; 20(1):65-74. PubMed ID: 8461881
[TBL] [Abstract][Full Text] [Related]
9. Biotin-conjugated polychelating agent.
Torchilin VP
Bioconjug Chem; 1999; 10(1):146-9. PubMed ID: 9893977
[TBL] [Abstract][Full Text] [Related]
10. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
[TBL] [Abstract][Full Text] [Related]
11. A fluorescence quenching method for estimating chelating groups in chelate-conjugated macromolecules.
Ma W; Hwang KJ; Lee VH
Pharm Res; 1993 Feb; 10(2):204-7. PubMed ID: 8456066
[TBL] [Abstract][Full Text] [Related]
12. Coupling of DTPA to proteins: a critical analysis of the cyclic dianhydride method in the case of insulin modification.
Maisano F; Gozzini L; de Haën C
Bioconjug Chem; 1992; 3(3):212-7. PubMed ID: 1520724
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
[TBL] [Abstract][Full Text] [Related]
14. Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
Turner A; King DJ; Farnsworth AP; Rhind SK; Pedley RB; Boden J; Boden R; Millican TA; Millar K; Boyce B
Br J Cancer; 1994 Jul; 70(1):35-41. PubMed ID: 8018538
[TBL] [Abstract][Full Text] [Related]
15. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
Karczmarczyk U; Garnuszek P; Maurin M; Di Gialleonardo V; Galli F; Signore A; Mikołajczak R
Nucl Med Biol; 2010 Oct; 37(7):795-803. PubMed ID: 20870154
[TBL] [Abstract][Full Text] [Related]
16. Concise site-specific synthesis of DTPA-peptide conjugates: application to imaging probes for the chemokine receptor CXCR4.
Masuda R; Oishi S; Ohno H; Kimura H; Saji H; Fujii N
Bioorg Med Chem; 2011 May; 19(10):3216-20. PubMed ID: 21524584
[TBL] [Abstract][Full Text] [Related]
17. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.
Bogdanov A; Kang HW; Querol M; Pretorius PH; Yudina A
Bioconjug Chem; 2007; 18(4):1123-30. PubMed ID: 17508710
[TBL] [Abstract][Full Text] [Related]
19. Binding properties of 111In-diethylenetriaminepentaacetic acid (DTPA)-fragment E1,2, a fibrin-specific probe, are dependent on use of protecting complex during attachment of DTPA groups.
Knight LC; Kollmann M; Maurer AH; Budzynski AZ
Biochim Biophys Acta; 1987 Apr; 924(1):45-53. PubMed ID: 2950931
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of two (111)In-labeled DTPA-peptide conjugates.
Liu S; Edwards DS
Bioconjug Chem; 2001; 12(4):630-4. PubMed ID: 11459469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
